• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    12/30/25 4:28:50 PM ET
    $NTRB
    Industrial Specialties
    Health Care
    Get the next $NTRB alert in real time by email
    false 0001676047 0001676047 2025-12-30 2025-12-30 0001676047 us-gaap:CommonStockMember 2025-12-30 2025-12-30 0001676047 NTRB:WarrantsMember 2025-12-30 2025-12-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549 

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of

    the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported); December 30, 2025

     

    Nutriband Inc.

     

    Nevada   000-40854   81-1118176
    (State or Other Jurisdiction
    of Incorporation)
      (Commission File Number)   (I.R.S. Employer
    Identification No.)

     

    121 S. Orange Ave. Suite 1500
    Orlando, Florida
      32801
    (Address of Principal Executive Offices)   (Zip Code)

     

    (407) 377-6695

    Registrant’s Telephone Number, Including Area Code

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock   NTRB   The Nasdaq Stock Market LLC
    Warrants   NTRBW   The Nasdaq Stock Market LLC

     

     

     

     

     

    Item 7.01. Regulation FD Disclosure.

     

    See attached press release dated December 29, 2025.

     

    Item 9.01 Financial Statements and Exhibits

     

    (d) Exhibits

     

    The following exhibits are being filed with this Current Report on Form 8-K:

     

    99.1   Press Release issued December 29, 2025.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    1

     

     

    SIGNATURES

     

    PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

     

      NUTRIBAND, INC.
         
    Date: December 30, 2025 By:  /s/ Gareth Sheridan
        R: Gareth Sheridan
        Chief Executive Officer

     

    2

     

    Get the next $NTRB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTRB

    DatePrice TargetRatingAnalyst
    1/22/2025$13.00Outperform
    Noble Capital Markets
    More analyst ratings

    $NTRB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutriband CEO Publishes Letter to Shareholders

    ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 and the potential outlook for 2026. The full text of the letter is below. Dear Shareholders, As we wrapped up a successful 2025, the entire team at Nutriband would like to extend our warmest appreciation to all of you for your continued support throughout 2025 and into 2026. I always stress and extend our appreciation to the many of you that have been with us from the beginning and now the many more who have joined our common goal along the way. This goal

    12/31/25 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

    Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe Nutriband Inc. Shareholders will retain 10% of the shareholding in Earth Vision Bio following the acquisition The expected closing date for the transaction is Dec 31, 2025. ORLANDO, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), today announced that it has signed an agreement to sell a 90% interest in its subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio. Earthvision Bio has developed and are commercializing a new category of sustainable p

    12/29/25 9:00:00 AM ET
    $INTC
    $NTRB
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration

    ORLANDO, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company"), a developer of transdermal pharmaceutical products including abuse-deterrent technologies, today announced the signing of a non-binding Letter of Intent ("LOI") with the Qvanta Group of Companies. The Qvanta Group comprises Qvanta LLC and its subsidiaries, Qvanta Foundry LLC and Qvanta Capital LLC (collectively, "Qvanta"). Qvanta is a U.S.-based advanced technology organization developing the BigΔx Quantum Defense Fabric, an integrated quantum-AI cybersecurity and computing platform designed to support enterprise, government, and high-security research environments.

    12/18/25 8:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Noble Capital Markets initiated coverage on Nutriband with a new price target

    Noble Capital Markets initiated coverage of Nutriband with a rating of Outperform and set a new price target of $13.00

    1/22/25 9:24:55 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    SEC Filings

    View All

    Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - NutriBand Inc. (0001676047) (Filer)

    12/30/25 4:28:50 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form DEF 14A filed by Nutriband Inc.

    DEF 14A - NutriBand Inc. (0001676047) (Filer)

    12/19/25 11:01:52 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - NutriBand Inc. (0001676047) (Filer)

    10/28/25 12:00:00 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 5 filed by Sheridan Gareth

    5 - NutriBand Inc. (0001676047) (Issuer)

    11/25/25 5:12:40 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    Goodman Gerald exercised 60,085 in-the-money shares at a strike of $1.93, increasing direct ownership by 1,001% to 66,085 units (SEC Form 5)

    5 - NutriBand Inc. (0001676047) (Issuer)

    10/21/25 1:50:53 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Chief Financial Officer Goodman Gerald

    4 - NutriBand Inc. (0001676047) (Issuer)

    12/2/24 3:49:25 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Leadership Updates

    Live Leadership Updates

    View All

    Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

    ORLANDO, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (the "Company") is pleased to announce that it has been invited to present on the Emerging Growth Conference on August 20, 2025. The next Emerging Growth Conference is presenting on August 20, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chairman, Serguei Melnik in real time. Mr. Melnik will perform a presentation and may subsequently open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event and Mr. Melnik will do his best to

    8/18/25 9:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

    The Glinka family invested $4.5 million into Nutriband through the Company's April 2024 private placementORLANDO, FL / ACCESSWIRE / May 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, today announced the appointment of Sergei Glinka to its board of directors. Glinka is a seasoned and highly respected business executive with an impressive track record in leadership roles across major European companies.Mr. Glinka, an Estonian citizen, is an experienced and highly regarded businessman who has held numerous Executive and Board positions in large European Companies providing Glinka with deep insights and networks across various industri

    5/16/24 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Financials

    Live finance-specific insights

    View All

    Nutriband CEO Publishes Letter to Shareholders

    ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 and the potential outlook for 2026. The full text of the letter is below. Dear Shareholders, As we wrapped up a successful 2025, the entire team at Nutriband would like to extend our warmest appreciation to all of you for your continued support throughout 2025 and into 2026. I always stress and extend our appreciation to the many of you that have been with us from the beginning and now the many more who have joined our common goal along the way. This goal

    12/31/25 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

    ORLANDO, Fla., July 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") is today reminding shareholders of the key dates associated with its upcoming 25% Preferred stock dividend. Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August. 5th. Each preferred share will be convertible to one share of common stock following FDA approval of the Company's AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an ann

    7/18/25 9:15:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

    ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") announced today that its Board of Directors has approved and declared a 25% preferred stock dividend. Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August 5th. Each preferred share will be convertible to one share of common stock following FDA approval of the Company's AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an annual bas

    7/2/25 8:05:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $NTRB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Nutriband Inc.

    SC 13D/A - NutriBand Inc. (0001676047) (Subject)

    9/19/24 11:38:15 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Nutriband Inc.

    SC 13G - NutriBand Inc. (0001676047) (Subject)

    2/13/24 8:33:52 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Nutriband Inc.

    SC 13G - NutriBand Inc. (0001676047) (Subject)

    2/12/24 3:57:44 PM ET
    $NTRB
    Industrial Specialties
    Health Care